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Conclusion:
– In diabetic patients undergoing coronary artery stenting, patients
with HbA1c levels 67% may have lower risk of restenosis and have
better clinical outcome after PCI at 2-year follow-up.
– Clopidogrel may reduce the risk of restenosis in diabetic patients
who underwent coronary artery stenting when used for more than
12 month or more (12–24 month).
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Background: CHD represents the most important component of pedi-
atric cardiovascular diseases. It has a high risk of morbidity and mor-
tality in newborns and infants. were considered as multifactorial
diseases. However genetic factors were considered as a corner stone
of their etiology. The DNA content represents the nuclear genomic
concentration. It is aﬀected by several multifactors.
Objective: The aim of our study was to determine the DNA content in
particular common congenital heart disease. To detect the correlation
between their DNA content and the chromosomal pattern as well as
with the hemodynamic aspect of CHD.
Material and methods: The present study was subjected on 30 children
suﬀering from the most common CHD and accordingly classiﬁed into
three groups; 1St (VSD) 2nd (TOF), 3’ (D-TGA), each included 10
cases with speciﬁc criteria and equally gender distribution, and ten
healthy age matched children as control group. All studied groups
were subjected to thorough clinical, functional, structural and hemody-
namic cardiac assessment as investigated via electrocardiogram, car-
diac X rays, full echocardiography, and cardiac catheterization
studies. Also full chromosomal, cytogenetic and DNA content studies
were applied.
Results: The value of structural and numerical chromosornal aberra-
tions was found to be signiﬁcantly higher in cyanotic congenital heart
disease (CCHD) than that of acyanotic congenital heart disease
(ACCHD). Current study revealed that there was a highly signiﬁcant
correlation between the incidence of the chromosomal aberrations
both structural and numerical as well as the aging and the mean values
of DNA content of CHD. Also there was highly signiﬁcant decreased
in DNA content values in CHD in comparison to control group and
the aﬀection in DNA content of (CCHD), was more aggressive than
in (ACCHD). However there was non signiﬁcant relation between
DNA content and the hemodynamic and function aspect of CHD.
Conclusion: DNA content of CHD was highly signiﬁcant reduced. It is
aﬀected by the incidence of chrornosomal aberrations, aging and the
cardiomyocytic apoptosis.
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Drug eluting balloons in femoro-popliteal artery disease
Ahmed S. Gaweesh.
Background: Treatment of femoropopliteal artery disease by percuta-
neous transluminal angioplasty (PTA) is limited by high rates of reste-
nosis (40% to 60%) 6 to 12 months after procedure. The high
mechanical stress (bending, compression, torsion) that occurs in the
femoropopliteal arteries with normal patient movement is associated
with an increased risk for stent fractures and in-stent restenosis. Fur-
thermore, the reduction of restenosis seen with drug-eluting stent treat-
ment of coronary artery disease was not observed in several studies of
drug-eluting stent use in femoropopliteal artery disease. Hence, an
alternative stent-free therapy that may similarly reduce restenosis
and improve clinical outcome has been sought.
Objectives: To review the recent clinical trials using drug-eluting bal-
loons (DEB) in treatment of femoropopliteal artery disease.
Methods: There are four already ﬁnished randomized studies in
patients with superﬁcial femoral artery lesions investigating the eﬃcacy
of paclitaxel release by DEB. Currently there is a rapidly increasing
clinical study program using DEB in diﬀerent locations and
indications.
Results: All 4 trials demonstrated signiﬁcantly improved patency rates
at 12 and 24 months angiographic follow-up compared to standard
PTA. DEB oﬀer several advantages compared to drug eluting stents,
since any stentless technology for improving long-term patency is pref-
erable to overcome the drawbacks of stenting in this mobile segment.
Conclusions: DEB technology has demonstrated the capacity to have a
signiﬁcant impact on the practice of percutaneous cardiovascular inter-
ventions in the future. Several clinical trials have demonstrated prom-
ising early and mid-term results in treating femoropopliteal lesions.
Long-term results, exact indications, and optimal applications are
yet to be determined.
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Early detection of left ventricular dysfunction in asymptomatic diabetic
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Background/aim: Diabetic cardiomyopathy is deﬁned as left ventricu-
lar dysfunction that occurs independently of coronary artery disease,
and hypertension. The aim of this study is to investigate early altera-
tions in left ventricular systolic and diastolic functions in patients with
type 2 diabetes mellitus using strain and strain rate Echo compared
with normal subjects.
Patients and methods: he present study enrolled forty subjects. They
were divided into two groups: Group (1): Patients with only type 2 dia-
betes mellitus (20 Patients).Group (2) Normal Subjects as controls (20
Patients).All patients of type 2 diabetes mellitus according to the WHO
criteria treated with oral hypo glycemic drugs. Mean age of diabetic
group is (53.05  7.02). All the studied groups were subjected to: full
history taking and clinical examination, resting 12 leads surface elec-
tro-cardiogram, laboratory assessment of Glycosylated Hb, standard
trans-thoracic echocardiography, tissue Doppler imaging, strain and
strain rate imaging.
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